Compare · HLF vs MEDS
HLF vs MEDS
Side-by-side comparison of Herbalife Ltd. (HLF) and TRxADE HEALTH Inc. (MEDS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HLF and MEDS operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- HLF is the larger of the two at $1.18B, about 77.9x MEDS ($15.2M).
- HLF has been more active in the news (20 items in the past 4 weeks vs 1 for MEDS).
- HLF has more recent analyst coverage (14 ratings vs 1 for MEDS).
- Company
- Herbalife Ltd.
- TRxADE HEALTH Inc.
- Price
- $11.38-0.22%
- $7.44+7.20%
- Market cap
- $1.18B
- $15.2M
- 1M return
- -30.02%
- -
- 1Y return
- +52.92%
- -
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NYSE
- NASDAQ
- IPO
- 2004
- News (4w)
- 20
- 1
- Recent ratings
- 14
- 1
Herbalife Ltd.
Herbalife Nutrition Ltd. offers nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, and the Asia Pacific. The company provides products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition. It offers weight management products, including meal replacement products, protein shakes, drink mixes, weight loss enhancers, and healthy snacks; targeted nutrition products, which include functional beverages, and dietary and nutritional supplements that contain herbs, vitamins, minerals, and other natural ingredients; outer nutrition products, such as facial skin, body, and hair care products; and energy, sports, and fitness products comprising N-R-G tea and energy drink products. The company also provides literature, promotional, and other materials that include start-up kits, sales tools, and educational materials. It offers its products through independent service providers and sales representatives, as well as through company-operated retail platforms. The company was formerly known as Herbalife Ltd. and changed its name to Herbalife Nutrition Ltd. in April 2018. Herbalife Nutrition Ltd. was founded in 1980 and is headquartered in Los Angeles, California.
TRxADE HEALTH Inc.
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.
Latest HLF
- Director L'Helias Sophie bought $13,572 worth of shares (1,200 units at $11.31), increasing direct ownership by 2% to 79,882 units (SEC Form 4)
- Herbalife Named to Three 2026 USA TODAY Most Trusted Brands Lists
- Herbalife Chief Financial Officer to Present at East Coast IDEAS Conference on June 11
- Amendment: New insider Walsh Des claimed ownership of 50,000 shares (SEC Form 3)
- Chief Operating Officer Hicks Troy sold $619,556 worth of shares (48,377 units at $12.81), exercised 83,270 shares at a strike of $9.31 and covered exercise/tax liability with 72,626 shares, decreasing direct ownership by 80% to 9,706 units (SEC Form 4)
- Roman DBDR Acquisition Corp. II Appoints Hunter Gary to Board of Directors and Al Basseri as Chief Technology Officer, Ahead of Proposed Business Combination with ThomasLloyd Climate Solutions
- Chief Commercial Officer Lamberti Frank sold $1,932,259 worth of shares (142,919 units at $13.52), decreasing direct ownership by 80% to 36,624 units (SEC Form 4)
- Director Cloud Lynda was granted 11,879 shares, increasing direct ownership by 31% to 50,736 units (SEC Form 4)
- Director Otero Maria was granted 11,879 shares, increasing direct ownership by 14% to 95,129 units (SEC Form 4)
- Director Carmona Richard H was granted 11,879 shares, increasing direct ownership by 17% to 83,645 units (SEC Form 4)
Latest MEDS
- SCIENTURE to Present at The Small Cap Showcase & WTR Insights on June 9, 2026, in NYC
- Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value
- Oragenics, Inc. Provides Shareholder Update on Strategic Progress and Announces Janet Huffman as Interim CEO
- TRxADE HEALTH Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
- TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to "SCNX"
- TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.
- SEC Form DEF 14C filed by TRxADE HEALTH Inc.
- SEC Form PRE 14C filed by TRxADE HEALTH Inc.
- SEC Form 10-Q filed by TRxADE HEALTH Inc.
- New insider Shankar Hariharan claimed ownership of 97,087 shares (SEC Form 3)